Both in Pharmaceuticals
Grace Therapeutics vs Werewolf Therapeutics
Over the past year GRCE returned −29.0% and HOWL returned −58.4%; their daily moves had a correlation of 0.11.
GRCE −29.0% HOWL −58.4%Growth of $1, one year, split-adjusted
| Metric | GRCE | HOWL |
|---|---|---|
| Price | $2.11 | $0.9100 |
| Market cap | $44.4M | $44.2M |
| Today | −0.47% | −2.15% |
| 1 month | −0.5% | −3.5% |
| 6 months | −51.6% | +14.2% |
| Year to date | −39.0% | +43.6% |
| 1 year | −31.7% | −56.0% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | 100.0% |
| Net margin | — | 17.5% |
| P/E (TTM) | — | — |
| Price / sales | — | 2.1× |
| Net cash | $13.8M | $22.0M |
| Dividend yield | — | — |
| Volatility (60d) | 33.5% | 176.7% |
| Short % of float | 11.7% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).